5 results  1 of 1 

1 Chimeric Antigen Receptor T Cell Therapy: A Novel Modality for Immune Modulation
Somy Yoon, Gwang Hyeon Eom
Chonnam Med J.2020;56(1):6-11.   Published online 2020 January 22     DOI: http://dx.doi.org/10.4068/cmj.2020.56.1.6
      
2 Can oliceridine (TRV130), an ideal novel µ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?
Hwoe Gyeong Ok, Su Young Kim, Su Jung Lee, Tae Kyun Kim, Billy K Huh, Kyung Hoon Kim
Korean J Pain.2018;31(2):73-79.   Published online 2018 April 2     DOI: http://dx.doi.org/10.3344/kjp.2018.31.2.73
      
3 Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer
Sumi Yun, Yoonjin Kwak, Soo Kyung Nam, An Na Seo, Heung-Kwon Oh, Duck-Woo Kim, Sung-Bum Kang, Hye Seung Lee
Cancer Res Treat.2018;50(4):1351-1361.   Published online 2018 January 17     DOI: http://dx.doi.org/10.4143/crt.2017.487
      
4 The Protective Role of TLR3 and TLR9 Ligands in Human Pharyngeal Epithelial Cells Infected with Influenza A Virus
Yan Han, Zhi-jian Bo, Ming-yu Xu, Nan Sun, Dan-hong Liu
Korean J Physiol Pharmacol.2014;18(3):225-231.   Published online 2014 June 12     DOI: http://dx.doi.org/10.4196/kjpp.2014.18.3.225
      
5 Targeting the Peroxisome Proliferator-Activated Receptor-γ to Counter the Inflammatory Milieu in Obesity
Cesar Corzo, Patrick R. Griffin
Diabetes Metab J.2013;37(6):395-403.   Published online 2013 December 12     DOI: http://dx.doi.org/10.4093/dmj.2013.37.6.395
      

 1 of 1